UF Innovate | Sid Martin Biotech alum RTI Surgical, Inc., a global surgical implant company, announced that Cigna Corporation, a global health service company, issued a positive medical coverage policy for minimally invasive sacroiliac (SI) joint fusion under certain medically necessary criteria. This policy covers the use of all FDA-cleared implants placed across the SI joint and intended to promote bone fusion, including the use of RTI’s SImmetry® Sacroiliac Joint Fusion System. The SImmetry System is a minimally invasive surgical solution that uses proprietary decortication technology, bone grafting, and threaded fixation to facilitate bone fusion, providing an opportunity for long-term pain relief.
“RTI is pleased with Cigna’s new coverage policy for minimally invasive SI joint fusion procedures, including those completed with our SImmetry System,” said Camille Farhat, president and CEO. “Our clinical distinction for the SImmetry System continues to strengthen, with interim results of the EVoluSIon study for 148 patients at 12 months showing 71 percent of patients with significant pain reduction, a 60 percent decrease in the number of patients using opioids and 86 percent of patients satisfied with their SImmetry System implant.”Learn more about RTI Surgical® Announces Cigna’s Positive Medical Coverage Policy for Minimally Invasive SI Joint Fusion Surgery.